Evidence map›Paper›PMID 31628475›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2020

Smoking Topography Characteristics During a 6-Week Trial of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness.

Rachel L Denlinger-Apte, Eric C Donny, Bruce R Lindgren, Nathan Rubin, Christine Goodwin, Teresa DeAtley, Suzanne M Colby, Patricia A Cioe, Dorothy K Hatsukami, Jennifer W Tidey

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Regulatory Approaches and Implementation of Minimally Addictive Combusted Products.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Rachel L Denlinger-ApteDepartment of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC.
Eric C DonnyBaptist Comprehensive Cancer Center and Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC.
Bruce R LindgrenMasonic Cancer Center, University of Minnesota, Minneapolis, MN.
Nathan RubinMasonic Cancer Center, University of Minnesota, Minneapolis, MN.
Christine GoodwinCenter for Alcohol and Addiction Studies, School of Public Health, Brown University, Providence, RI.
Teresa DeAtleyDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI.
Suzanne M ColbyCenter for Alcohol and Addiction Studies, School of Public Health, Brown University, Providence, RI.
Patricia A CioeCenter for Alcohol and Addiction Studies, School of Public Health, Brown University, Providence, RI.
Dorothy K HatsukamiMasonic Cancer Center and Department of Psychiatry, University of Minnesota, Minneapolis, MN.
Jennifer W TideyCenter for Alcohol and Addiction Studies, School of Public Health, Brown University, Providence, RI.
Brown University · USUniversity of Minnesota · USAtrium Health Wake Forest Baptist · USWake Forest University · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIAU54DA031659 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HATSUKAMI, DOROTHY K · 2011 to 2022
$64.7M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
University of Vermont Tobacco Center of Regulatory ScienceU54DA036114 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2018 to 2022
$19.4M
Substance Abuse Intervention/Outcome Research TrainingT32DA016184 · NIDA · BROWN UNIVERSITY · PI Damaris J. Rohsenow, JENNIFER W. TIDEY · 2003 to 2026
$6.1M
Cancer Prevention And Control Training Grant (CAPACITY)T32CA122061 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KRISTIE L FOLEY, Kathryn Elizabeth Weaver · 2019 to 2026
$2.1M
Evaluation of Very Low Nicotine Content Cigarettes in Adolescent SmokersK01CA189300 · NCI · BROWN UNIVERSITY · PI CASSIDY, RACHEL N · 2014 to 2018
$897k
Biopsychosocial Factors Associated with Cigarette and E-cigarette Use in Smokers with Affective DisordersF31DA049460 · NIDA · BROWN UNIVERSITY · PI DEATLEY, TERESA E · 2019 to 2021
$115k
Assessing Tobacco Product Choice When the Cost of Menthol Cigarettes IncreasesR36DA045183 · NIDA · BROWN UNIVERSITY · PI DENLINGER-APTE, RACHEL · 2018 to 2019
$107k
NCATS NIH HHS UL1 TR002494NCI NIH HHS K01 CA189300NCI NIH HHS P30 CA077598NCI NIH HHS T32 CA122061NIDA NIH HHS F31 DA049460NIDA NIH HHS R36 DA045183NIDA NIH HHS T32 DA016184NIDA NIH HHS U54 DA031659NIDA NIH HHS U54 DA036114
6 · The paper itself

Abstract

introductionA nicotine-reduction policy could have major benefits for smokers with serious mental illness (SMI). However, potential unintended consequences, such as compensatory smoking, should be considered to ensure that such a policy does not negatively affect this population. The purpose of this secondary analysis was to examine the impact of smoking very low nicotine content (VLNC) cigarettes for 6 weeks on smoking topography characteristics, indicators of compensatory smoking, among smokers with SMI. AIMS AND

methodsAfter a baseline usual brand smoking phase, smokers with SMI (N = 58) were randomly assigned under double-blind conditions to receive either VLNC (0.4 mg nicotine per g tobacco) or normal nicotine content (NNC; 15.8 mg nicotine per g tobacco) research cigarettes for 6 weeks. During two study visits scheduled 6 weeks apart, participants smoked either their usual brand (baseline) or assigned study cigarettes (postrandomization) through a handheld smoking topography device. Univariate analysis of variance compared smoking topography indices with cigarette condition (VLNC vs. NNC) as the between-subjects factor with corresponding baseline topography results included as covariates.

resultsAt week 6, participants in the VLNC condition smoked fewer puffs per cigarette and had shorter interpuff intervals compared to participants in the NNC condition (ps < .05). There were no differences between research cigarette conditions at week 6 for cigarette volume, puff volume, puff duration, peak flow rate, or carbon monoxide boost.

conclusionsFindings are consistent with acute VLNC cigarette topography studies and indicate that a nicotine-reduction policy is unlikely to lead to compensation among smokers with SMI. IMPLICATIONS: Given the high smoking rates among people with SMI, understanding how a nicotine-reduction policy may affect this population is critically important. When considering the smoking topography results as a whole, smokers with SMI did not engage in compensatory smoking behavior when using VLNC cigarettes during a 6-week trial. Study findings suggest that compensatory smoking is not likely to occur among smokers with SMI if nicotine content is lowered to minimally addictive levels.

Indexed as

AdolescentAdultAgedBehavior, AddictiveDouble-Blind MethodFemaleHumansMaleMental DisordersMiddle AgedNicotineSmokersSmokingSmoking CessationTobacco ProductsYoung AdultNicotine

Identifiers

PMID31628475
PMCPMC7364846
OpenAlexW2980480052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.